MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Alpha-synuclein"

  • 2019 International Congress

    Exosomes from patients with Parkinson’s disease are pathological in mice

    C. Han, N. Xiong, X. Guo, J. Huang, K. Ma, L. Liu, Y. Xia, S. Yin, L. Kou, F. Wan, J. Hu, G. Zhang, T. Wang (Wuhan, China)

    Objective: To verify the hypothesis that serum-derived exosomes from patients with Parkinson’s disease (PD) may serve as risk carriers for inter-neuronal risk transmission, eventually resulting…
  • 2019 International Congress

    Alpha-synuclein expression and cytokine profile in blood of patients with Lewy body dementias

    T. Usenko, M. Nikolaev, A. Bezroukova, A. Emelyanov, E. Gracheva, I. Milukhina, Y. Belceva, N. Zalutskaya, A. Timofeeva, S. Pchelina (Gatchina, Russian Federation)

    Objective: To examine alpha-synuclein expression in CD45+ and cytokine levels in blood of patients with dementia with Lewy bodies (DLB), Parkinson's disease dementia (PDD). Background:…
  • 2019 International Congress

    Microglia as modulators of exosomal alpha-synuclein transmission

    Y. Xia, T. Wang, GX. Zhang, JS. Huang, N. Xiong, L. Liu, F. Wan, L. Kou, SJ. Yin, JJ. Hu, YD. Sun, JW. Wu (Wuhan, China)

    Objective: It is highly desirable to make clear the underlying mechanism of exosomes-involved communication in the synucleinopathy pathogenesis. Background: Emerging evidence suggests that exogenous pathogenic…
  • 2019 International Congress

    Behavioural aspect of transgenic Drosophila melanogaster as a model of Parkinson’s disease treated by Ropinirole alginate nanocomposite

    F. Naz, R. X, YHS. Siddique (Aligarh, India)

    Objective: To evaluate the behavioural changes in transgenic Drosophila melanogaster as a model of Parkinson’s disease treated by different doses of Ropinirole alginate nanocomposite (RANC).…
  • 2019 International Congress

    Decreased serum alpha-synuclein in patients with Restless Legs Syndrome and association with SNCA-Rep1 polymorphism

    YC. Wu, XY. Zhu, TT. Wu, T. Liu, HM. Wang, YJ. Chen, X. Li, XX. Cui (Shanghai, China)

    Objective: To investigate whether α -synuclein levels are altered in serum and saliva in patients with RLS and explore influence of the SNCA-Rep1 microsatellite repeat…
  • 2019 International Congress

    Impaired lysosomal catabolism of alpha-synuclein in parkinsonian LRRK2(R1441G) mutant mouse embryonic fibroblasts

    WL. Ho, CT. Leung, HF. Liu, LF. Li, DB. Ramsden, SL. Ho (Hong Kong, Hong Kong)

    Objective: Using a unique fluorescence-based flow cytometry assay on LRRK2(R1441G) mutant mouse embryonic fibroblasts (MEFs) to elucidate whether pathogenic LRRK2 mutation affects cellular lysosomal degradation…
  • 2019 International Congress

    Alpha-synuclein seeding activity in blood samples from synucleinopathy patients

    T. Yamasaki, E. Song (Lexington, KY, USA)

    Objective: Utilize a cell-based assay to determine whether a-syn seeding activity can be amplified and  detected from blood components from patients with Parkinson’s disease (PD)…
  • 2019 International Congress

    Appendectomy and risk of Parkinson’s disease: A meta-analysis using real-world evidence

    S. Hussain, A. Najmi (New Delhi, India)

    Objective: This meta-analysis is aimed to explore the association between appendectomy and Parkinson’s disease (PD) risk. Background: Parkinson’s disease is recently recognized as a systematic…
  • 2019 International Congress

    Autonomic features in E46K-SNCA carriers

    M. Carmona-Abellán, I. Gabilondo, A. Murueta, V. Khurana, R. Luquin, B. Tijero, R. Del Pino, M. Acera, R. Sanchez-Pernaute, JC. Gomez-Esteban (Bilbao, Spain)

    Objective: To evaluate structural and functional integrity of small autonomic nerve fibers and phosphorylated alpha-synuclein (p-syn) deposition in the skin of E46K-SNCA carriers as compared…
  • 2019 International Congress

    SNCA G51D missense mutation causing juvenile onset Parkinson’s disease

    C. Cooper, J. Goldman, C. Zabetian, I. Mata, J. Leverenz (Chicago, IL, USA)

    Objective: To report the clinical and genetic features in a Parkinson’s patient with the SNCA G51D missense mutation. Background: α-synuclein (SNCA) gene mutations are recognized…
  • « Previous Page
  • 1
  • …
  • 28
  • 29
  • 30
  • 31
  • 32
  • …
  • 51
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
    • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Life expectancy with and without Parkinson’s disease in the general population
    • An atypical and interesting feature of Parkinson´s disease
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Effect of marijuana on Essential Tremor: A case report
    • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
    • Covid vaccine induced parkinsonism and cognitive dysfunction
    • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Patients with Essential Tremor Live Longer than their Relatives
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley